ABeta amyloidosis, Italian type

Last reviewed

🖨 Print for my doctorAdvocacy Hub →
ORPHA:324713OMIM:605714I68.0*E85.4+
Who is this for?
Show terms as
8Treatment centers

Where are you in your journey?

UniteRare data is sourced from FDA.gov, ClinicalTrials.gov, Orphanet, OMIM, and NORD.
Report missing data

Overview

ABeta amyloidosis, Italian type, is an extremely rare inherited condition caused by a specific mutation in the APP gene, which provides instructions for making amyloid precursor protein. This mutation leads to the abnormal buildup of a protein called amyloid-beta in the walls of blood vessels in the brain, a condition known as cerebral amyloid angiopathy (CAA). Over time, this protein deposit weakens blood vessel walls, making them fragile and prone to bleeding. The disease primarily affects the brain and its blood vessels. People with this condition typically develop symptoms in adulthood, often including recurrent strokes caused by bleeding in the brain (hemorrhagic strokes), progressive cognitive decline or dementia, and sometimes seizures. Headaches and neurological problems such as weakness or difficulty speaking may also occur, especially during or after a bleeding episode. There is currently no cure for ABeta amyloidosis, Italian type. Treatment focuses on managing symptoms, preventing further bleeding events, and providing supportive care. Blood pressure control is important to reduce the risk of hemorrhagic strokes. Rehabilitation services, including physical therapy, occupational therapy, and speech therapy, may be needed after stroke events. The disease was originally identified in families of Italian descent, which is how it received its name.

Also known as:

Key symptoms:

Recurrent strokes caused by brain bleedingProgressive memory loss and dementiaSeizuresSevere headachesWeakness on one side of the bodyDifficulty speaking or understanding speechVision changesConfusion or disorientationPersonality or behavior changesDifficulty with balance and coordinationCognitive decline over time

Clinical phenotype terms (7)— hover any for plain English
Inheritance

Autosomal dominant

Passed on from just one parent; each child has about a 50% chance of inheriting it

Age of Onset

Adult

Begins in adulthood (age 18 or older)

Orphanet ↗OMIM ↗NORD ↗

Treatments

No FDA-approved treatments are currently listed for ABeta amyloidosis, Italian type.

View clinical trials →

No actively recruiting trials found for ABeta amyloidosis, Italian type at this time.

New trials open frequently. Follow this disease to get notified.

Search ClinicalTrials.gov ↗Join the ABeta amyloidosis, Italian type community →

No specialists are currently listed for ABeta amyloidosis, Italian type.

View NORD Rare Disease Centers ↗Undiagnosed Disease Network ↗

Treatment Centers

8 centers
🏥 NORD

Baylor College of Medicine Rare Disease Center

Baylor College of Medicine

📍 Houston, TX

🏥 NORD

Stanford Medicine Rare Disease Center

Stanford Medicine

📍 Stanford, CA

🔬 UDN

NIH Clinical Center Undiagnosed Diseases Program

National Institutes of Health

📍 Bethesda, MD

🔬 UDN

UCLA UDN Clinical Site

UCLA Health

📍 Los Angeles, CA

🔬 UDN

Baylor College of Medicine UDN Clinical Site

Baylor College of Medicine

📍 Houston, TX

🔬 UDN

Harvard/MGH UDN Clinical Site

Massachusetts General Hospital

📍 Boston, MA

🏥 NORD

Mayo Clinic Center for Individualized Medicine

Mayo Clinic

📍 Rochester, MN

👤 Mayo Clinic Center for Individualized Medicine

🏥 NORD

UCLA Rare Disease Day Program

UCLA Health

📍 Los Angeles, CA

Travel Grants

No travel grants are currently matched to ABeta amyloidosis, Italian type.

Search all travel grants →NORD Financial Assistance ↗

Community

Open ABeta amyloidosis, Italian typeForum →

No community posts yet. Be the first to share your experience with ABeta amyloidosis, Italian type.

Start the conversation →

Latest news about ABeta amyloidosis, Italian type

No recent news articles for ABeta amyloidosis, Italian type.

Follow this condition to be notified when news becomes available.

Caregiver Resources

NORD Caregiver Resources

Support, advocacy, and financial assistance for caregivers of rare disease patients.

Mental Health Support

Rare disease caregiving can be isolating. Connect with counseling and peer support.

Family & Caregiver Grants

Financial assistance programs specifically for caregivers of rare disease patients.

Social Security Disability

Learn how rare disease patients may qualify for SSDI/SSI benefits.

Questions for your doctor

Bring these to your next appointment

  • Q1.What specific APP gene mutation do I have, and what does it mean for my prognosis?,Should my family members be tested for this genetic mutation?,What medications should I avoid because they could increase my risk of brain bleeding?,What is my target blood pressure, and how should I monitor it at home?,What are the warning signs of a new brain bleed, and when should I go to the emergency room?,Are there any clinical trials or experimental treatments I might be eligible for?,What rehabilitation or support services are available to help me maintain my independence?

Common questions about ABeta amyloidosis, Italian type

What is ABeta amyloidosis, Italian type?

ABeta amyloidosis, Italian type, is an extremely rare inherited condition caused by a specific mutation in the APP gene, which provides instructions for making amyloid precursor protein. This mutation leads to the abnormal buildup of a protein called amyloid-beta in the walls of blood vessels in the brain, a condition known as cerebral amyloid angiopathy (CAA). Over time, this protein deposit weakens blood vessel walls, making them fragile and prone to bleeding. The disease primarily affects the brain and its blood vessels. People with this condition typically develop symptoms in adulthood, o

How is ABeta amyloidosis, Italian type inherited?

ABeta amyloidosis, Italian type follows a autosomal dominant inheritance pattern. Genetic counseling can help families understand recurrence risk and testing options.

At what age does ABeta amyloidosis, Italian type typically begin?

Typical onset of ABeta amyloidosis, Italian type is adult. Age of onset can vary across affected individuals.